Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02277782 · ClinicalTrials.gov registry record · NA
Intrathecal Hydromorphone for Labor Analgesia
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02277782 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 21 participants.
The verdict
NCT02277782, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will: 1. Prolong the duration and improve the quality of analgesia in labor, and 2. Decrease the incidence of epidural-associated temperature increase in labor.
Interventions
- DRUG Hydromorphone
- DRUG Fentanyl
- DRUG Hyperbaric bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02277782
The ClinicalTrials.gov registry entry for NCT02277782 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hydromorphone is the first listed.
NCT02277782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02277782 about?
NCT02277782 is a clinical study titled "Intrathecal Hydromorphone for Labor Analgesia". The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will: 1. Prolong...
What is the current status of trial NCT02277782?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2015-09-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02277782?
The interventions under investigation include: Hydromorphone (DRUG), Fentanyl (DRUG), Hyperbaric bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02277782?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.